Showing results (621-630 of 695) with videos related to

Sort By:
Pageof 70
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysisSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
British Journal of Cancer|May 29, 2014
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)E L Turner, C Metcalfe, J L Donovan, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
Plos One|December 2, 2011
Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS dataJyotsna Batra, Felicity Lose, Tracy O'Mara, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Urologic Oncology|July 12, 2011
Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressivenessFelicity Lose, Jyotsna Batra, Tracy O'Mara, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
British Journal of Cancer|July 17, 2020
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancerSian M Noble, Kirsty Garfield, J Athene Lane, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Specificity of a polygenic score for aggressive prostate cancerAnna M Dornisch, George J Xu, Roshan Karunamuni, et al.
Pageof 70